Nifty
Sensex
:
:
10020.65
32382.46
56.10 (0.56%)
154.19 (0.48%)

Pharmaceuticals & Drugs

Rating :
13/99

BSE: 532300 | NSE: WOCKPHARMA

621.45
-14.10 (-2.22%)
26-Jul-2017 | 3:57PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 622.05
  • 633.70
  • 617.25
  • 635.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 732072
  • 4549.46
  • 1037.00
  • 555.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,020.21
  • N/A
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,431.27
  • 1.61%
  • 2.14

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.25%
  • 1.83%
  • 14.12%
  • FII
  • DII
  • Others
  • 0.1%
  • 2.61%
  • 7.09%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Sep 16
Sep 15
Var%
Jun 16
Jun 15
Var%
Net Sales
863.53
1,013.36
-14.79%
995.56
1,075.77
-7.46%
1,064.69
1,231.65
-13.56%
1,090.83
1,140.65
-4.37%
Expenses
1,040.18
944.53
10.13%
994.61
1,008.25
-1.35%
965.18
1,046.89
-7.81%
1,015.49
973.39
4.33%
EBITDA
-176.65
68.83
-
0.95
67.52
-98.59%
99.51
184.76
-46.14%
75.34
167.26
-54.96%
EBIDTM
-20.46%
6.79%
0.10%
6.28%
9.35%
15.00%
6.91%
14.66%
Other Income
68.68
17.31
296.76%
22.42
49.43
-54.64%
19.90
6.91
187.99%
16.90
38.76
-56.40%
Interest
58.90
35.71
64.94%
61.42
25.26
143.15%
56.37
23.30
141.93%
48.58
16.94
186.78%
Depreciation
37.08
37.22
-0.38%
38.11
35.84
6.33%
37.36
34.85
7.20%
36.38
34.65
4.99%
PBT
-203.96
13.21
-
-76.16
55.85
-
25.68
133.52
-80.77%
7.28
154.43
-95.29%
Tax
3.27
-29.53
-
-15.72
2.73
-
0.76
18.74
-95.94%
-9.42
33.54
-
PAT
-207.22
42.74
-
-60.44
53.12
-
24.92
114.78
-78.29%
16.70
120.89
-86.19%
PATM
-24.00%
4.22%
-6.07%
4.94%
2.34%
9.32%
1.53%
10.60%
EPS
-15.81
3.88
-
-4.88
5.52
-
1.54
9.74
-84.19%
1.44
10.36
-86.10%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Dec 08
Dec 07
Net Sales
4,014.61
4,461.43
4,481.54
4,830.36
5,609.42
4,350.50
3,751.24
4,501.42
3,589.78
2,653.15
Net Sales Growth
-10.02%
-0.45%
-7.22%
-13.89%
28.94%
15.97%
-16.67%
25.40%
35.30%
 
Cost Of Goods Sold
1,662.07
1,604.21
1,487.48
1,806.25
1,747.56
1,534.38
1,516.22
1,972.54
1,360.35
992.76
Gross Profit
2,352.54
2,857.22
2,994.06
3,024.11
3,861.86
2,816.12
2,235.02
2,528.89
2,229.42
1,660.40
GP Margin
58.60%
64.04%
66.81%
62.61%
68.85%
64.73%
59.58%
56.18%
62.10%
62.58%
Total Expenditure
4,001.81
3,957.60
3,772.14
3,804.65
3,549.74
2,996.79
2,835.28
3,731.04
2,933.74
2,014.89
Power & Fuel Cost
110.10
113.99
101.40
92.17
97.08
80.38
55.83
58.36
56.99
47.66
% Of Sales
2.74%
2.56%
2.26%
1.91%
1.73%
1.85%
1.49%
1.30%
1.59%
1.80%
Employee Cost
966.51
944.30
868.87
768.63
655.90
572.91
542.41
730.30
629.10
458.88
% Of Sales
24.07%
21.17%
19.39%
15.91%
11.69%
13.17%
14.46%
16.22%
17.52%
17.30%
Manufacturing Exp.
211.02
228.07
236.03
240.85
180.06
115.03
110.79
135.10
137.51
62.40
% Of Sales
5.26%
5.11%
5.27%
4.99%
3.21%
2.64%
2.95%
3.00%
3.83%
2.35%
General & Admin Exp.
504.43
404.66
320.92
352.19
248.28
194.47
198.73
234.13
179.13
91.65
% Of Sales
12.56%
9.07%
7.16%
7.29%
4.43%
4.47%
5.30%
5.20%
4.99%
3.45%
Selling & Distn. Exp.
205.30
258.67
261.55
292.98
291.74
214.75
186.16
219.81
218.33
145.78
% Of Sales
5.11%
5.80%
5.84%
6.07%
5.20%
4.94%
4.96%
4.88%
6.08%
5.49%
Miscellaneous Exp.
342.38
403.70
495.89
251.58
329.12
284.87
225.14
380.80
352.33
145.78
% Of Sales
8.53%
9.05%
11.07%
5.21%
5.87%
6.55%
6.00%
8.46%
9.81%
8.13%
EBITDA
12.80
503.83
709.40
1,025.71
2,059.68
1,353.71
915.96
770.38
656.04
638.26
EBITDA Margin
0.32%
11.29%
15.83%
21.23%
36.72%
31.12%
24.42%
17.11%
18.28%
24.06%
Other Income
114.25
96.95
66.55
38.40
54.00
25.34
152.62
29.52
46.11
78.19
Interest
225.27
101.21
55.21
83.35
215.37
269.02
267.10
342.48
259.07
163.81
Depreciation
148.93
142.56
145.40
139.92
122.14
115.07
116.62
148.14
113.05
78.48
PBT
-247.15
357.01
575.34
840.84
1,776.17
994.96
684.86
309.29
330.03
474.15
Tax
-21.11
25.48
162.65
47.88
258.21
221.74
8.65
16.67
-91.62
91.66
Tax Rate
8.54%
7.14%
28.27%
5.38%
14.05%
42.54%
8.29%
-1.69%
36.51%
19.33%
PAT
-195.72
325.02
404.91
840.72
1,579.48
299.45
95.70
-1,002.30
-159.34
382.49
PAT before Minority Interest
-226.04
331.53
412.69
842.79
1,579.48
299.45
95.70
-1,002.30
-159.34
382.49
Minority Interest
30.32
-6.51
-7.78
-2.07
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-4.88%
7.29%
9.04%
17.40%
28.16%
6.88%
2.55%
-22.27%
-4.44%
14.42%
PAT Growth
-160.22%
-19.73%
-51.84%
-46.77%
427.46%
212.90%
109.55%
-529.03%
-141.66%
 
Unadjusted EPS
-17.71
29.50
36.81
76.64
145.61
31.31
8.27
-91.44
-12.69
34.95

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Dec 08
Dec 07
Shareholder's Funds
3,336.71
3,872.41
3,715.35
3,581.47
2,704.18
1,471.02
943.10
671.75
1,017.73
1,273.56
Share Capital
55.27
353.80
353.59
353.43
353.34
816.09
799.93
723.30
54.72
54.72
Total Reserves
3,244.43
3,489.34
3,315.65
3,182.73
2,319.30
644.73
143.17
-51.55
963.01
1,218.84
Non-Current Liabilities
3,151.38
2,289.97
1,872.46
1,161.18
1,520.80
2,891.88
2,943.95
3,969.89
4,193.61
2,992.07
Secured Loans
2,887.11
1,650.80
1,180.25
1,096.27
1,467.51
2,697.34
2,785.34
3,552.21
3,160.86
2,344.02
Unsecured Loans
303.16
3.36
4.59
6.03
7.64
9.05
9.15
465.32
1,074.26
555.96
Long Term Provisions
94.23
588.22
635.05
51.98
69.85
84.49
224.31
0.00
0.00
0.00
Current Liabilities
1,925.82
1,842.33
1,772.97
1,743.20
1,773.48
1,890.94
1,919.01
1,031.27
1,630.28
911.01
Trade Payables
533.81
637.69
552.56
557.79
634.15
540.80
436.58
435.44
523.45
450.61
Other Current Liabilities
692.37
621.67
844.44
947.70
789.96
978.38
1,068.86
363.77
332.96
379.51
Short Term Borrowings
660.56
550.03
348.28
210.20
182.00
260.80
390.06
0.00
0.00
0.00
Short Term Provisions
39.08
32.94
27.69
27.51
167.37
110.96
23.51
232.05
773.87
80.89
Total Liabilities
8,795.85
8,475.08
7,504.73
6,622.02
5,998.46
6,253.84
5,806.06
5,672.91
6,841.62
5,176.64
Net Block
2,772.55
2,547.17
2,122.74
2,294.63
1,989.60
2,571.34
2,580.22
2,529.43
2,996.17
2,549.31
Gross Block
4,411.73
5,155.74
4,552.96
4,642.81
4,295.75
4,211.60
4,048.65
3,834.34
3,989.56
3,409.59
Accumulated Depreciation
1,639.18
2,608.57
2,430.22
2,348.18
1,684.94
1,306.76
1,439.10
1,038.73
988.17
860.27
Non Current Assets
4,179.81
4,484.51
3,983.17
3,266.10
2,671.53
3,772.33
3,903.85
3,331.83
3,722.87
3,142.21
Capital Work in Progress
1,243.95
1,036.05
1,007.30
707.53
490.94
902.29
862.70
707.57
633.50
444.59
Non Current Investment
0.45
0.45
2.62
2.62
2.63
90.75
89.63
94.83
93.19
70.94
Long Term Loans & Adv.
162.86
897.56
845.68
235.86
183.35
207.95
371.30
0.00
0.00
0.00
Other Non Current Assets
0.00
3.28
4.83
25.46
5.01
0.00
0.00
0.00
0.00
0.00
Current Assets
4,616.04
3,990.57
3,521.56
3,355.92
3,326.93
2,481.51
1,902.21
2,341.07
3,118.74
2,034.43
Current Investments
562.27
0.00
338.72
573.98
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,107.95
1,102.16
1,020.78
992.89
1,058.83
888.56
713.73
765.45
829.75
771.77
Sundry Debtors
1,034.45
1,200.47
741.43
481.04
958.46
758.69
605.24
574.01
853.42
670.07
Cash & Bank
1,603.61
1,478.11
1,234.55
1,125.80
1,096.06
699.99
482.89
346.98
649.91
380.18
Other Current Assets
307.76
0.00
0.00
0.00
213.58
134.27
100.35
654.63
785.65
212.41
Short Term Loans & Adv.
307.76
209.83
186.08
182.21
213.58
134.27
100.35
654.63
785.65
212.41
Net Current Assets
2,690.22
2,148.24
1,748.59
1,612.72
1,553.45
590.57
-16.80
1,309.80
1,488.46
1,123.42
Total Assets
8,795.85
8,475.08
7,504.73
6,622.02
5,998.46
6,253.84
5,806.06
5,672.90
6,841.61
5,176.64

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Dec 08
Dec 07
Dec 06
Cash From Operating Activity
71.61
354.96
1,476.29
1,532.40
1,343.83
641.81
-198.68
124.50
377.21
188.54
PBT
357.01
575.34
890.67
1,860.20
576.72
104.35
-985.64
-250.96
474.15
294.17
Adjustment
201.29
285.63
133.53
273.31
917.59
495.44
1,078.01
976.29
167.00
119.65
Changes in Working Capital
-402.76
-344.62
587.99
-266.99
-129.94
44.99
-244.20
-569.67
-197.65
-169.56
Cash after chg. in Working capital
155.54
516.35
1,612.19
1,866.52
1,364.37
644.78
-151.82
155.66
443.50
244.26
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-83.93
-161.39
-135.90
-334.12
-20.54
-2.97
-46.85
-31.15
-66.29
-55.72
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-818.19
-206.63
-851.62
1,085.37
-305.45
-276.61
704.33
-1,198.09
-1,667.73
-876.28
Net Fixed Assets
-268.53
-299.87
-283.99
174.15
-181.64
-415.22
-136.60
-330.13
-227.84
-171.71
Net Investments
0.00
10.73
0.00
0.00
0.00
7.69
-13.04
-0.13
-142.58
24.39
Others
-549.66
82.51
-567.63
911.22
-123.81
130.92
853.97
-867.83
-1,297.31
-728.96
Cash from Financing Activity
254.26
-75.65
-601.32
-2,245.75
-826.56
-372.99
-395.67
1,039.87
677.70
953.86
Net Cash Inflow / Outflow
-492.32
72.68
23.35
372.02
211.82
-7.79
109.98
-33.72
-612.83
266.12
Opening Cash & Equivalents
1,158.69
1,101.65
1,050.01
689.66
470.10
314.10
212.16
377.25
973.18
713.93
Closing Cash & Equivalent
664.64
1,158.69
1,101.65
1,050.01
689.66
470.10
314.10
212.16
380.18
973.18

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Dec 08
Dec 07
Book Value (Rs.)
298.51
320.78
306.20
294.97
216.65
63.91
18.08
0.29
93.00
116.37
ROA
-2.70%
4.15%
6.09%
13.36%
25.78%
4.97%
1.67%
-16.02%
-2.65%
8.60%
ROE
-6.42%
9.59%
12.49%
30.04%
102.78%
66.74%
95.20%
-196.36%
-13.91%
32.70%
ROCE
-0.31%
7.63%
11.25%
18.98%
43.10%
17.39%
8.23%
-12.94%
0.17%
17.70%
Fixed Asset Turnover
0.91
0.92
0.98
1.08
1.32
1.05
0.95
1.15
0.97
1.01
Receivable days
97.55
79.27
49.71
54.33
55.81
57.17
57.31
57.81
77.27
77.40
Inventory Days
100.47
86.66
81.88
77.43
63.29
67.16
71.89
64.61
81.23
82.19
Payable days
63.85
64.60
63.71
65.00
65.49
65.74
63.23
53.78
69.42
65.35
Cash Conversion Cycle
134.17
101.32
67.88
66.75
53.61
58.58
65.97
68.64
89.08
94.24
Total Debt/Equity
1.26
0.63
0.55
0.54
0.77
2.25
3.60
5.98
4.16
2.28
Interest Cover
-0.10
4.53
11.42
11.69
9.53
2.94
1.39
-1.88
0.03
3.89

News Update


  • Wockhardt receives final approval from USFDA for Olopatadine HCI
    4th Jul 2017, 08:54 AM

    The eye drop Olopatadine HCI 0.1% ophthalmic solution is a generic version of Patanol, marketed at US by Alcon, a subsidiary of Novartis

    Read More
  • Wockhardt settles ongoing commercial litigation with Teva
    23rd Jun 2017, 09:52 AM

    The dispute between the parties was in respect of the price charged by CP to its counterparty to the contract, Cephalon

    Read More
  • Wockhardt gets nod to raise up to Rs 1,000 crore
    9th Jun 2017, 14:59 PM

    The company earlier sought shareholders' approval through postal ballot

    Read More
  • HPRA grants GMP Compliance certificate to Wockhardt’s Shendra facility
    29th May 2017, 12:01 PM

    The inspection was performed by HPRA from February 27, 2017 to March 03, 2017

    Read More
  • Wockhardt seeks shareholders' nod to raise Rs 1000 crore
    9th May 2017, 09:09 AM

    The voting period for the company's shareholders begins on May 10 and ends on June 8, 2017

    Read More
  • Wockhardt gets nod to raise up to Rs 2200 crore
    5th May 2017, 09:52 AM

    The company has decided to raise up to Rs 1200 crore through issuance of non-convertible debentures (NCDs) on a private placement basis

    Read More
  • Wockhardt - Quarterly Results
    4th May 2017, 12:00 AM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.